Data / Form D filings / Aarden Pharmaceuticals, Inc.
Aarden Pharmaceuticals, Inc.: Form D filings
Aarden Pharmaceuticals, Inc., a pharmaceuticals company in Indianapolis, IN, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on January 3, 2011, reports $500,000 sold of a $500,000 offering to 2 investors.
Find out what Aarden Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 351 W. 10TH STREET, SUITE 248, Indianapolis, IN, 46202
- Phone
- (317) 690-2453
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1507273
The full lists. Form D filings in Indiana: 436 rows, $21.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 3, 2011 | Amendment | $500,000 | $500,000 | $0 | 2 | Nov 23, 2010 | sec.gov |
| Dec 8, 2010 | New notice | $250,000 | $250,000 | $0 | 1 | Nov 23, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary M. Noonan | Executive Officer, Director | |
| Zhong Yin Zhang | Director | |
| Christopher C. LeMasters | Director | |
| Francis J. Burrows | Executive Officer | |
| Thomas M. Estok | Director |
Every Form D from the week of Jan 3, 2011 · All recent filings in Indiana · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aarden Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.